nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—muscle cancer—testicular cancer	0.155	0.283	CtDrD
Dactinomycin—germ cell cancer—testicular cancer	0.139	0.254	CtDrD
Dactinomycin—kidney cancer—testicular cancer	0.129	0.237	CtDrD
Dactinomycin—sarcoma—testicular cancer	0.123	0.226	CtDrD
Dactinomycin—ABCC6—Vinblastine—testicular cancer	0.0645	0.173	CbGbCtD
Dactinomycin—ABCC6—Cisplatin—testicular cancer	0.0591	0.158	CbGbCtD
Dactinomycin—ABCC6—Etoposide—testicular cancer	0.0581	0.156	CbGbCtD
Dactinomycin—ABCC6—Doxorubicin—testicular cancer	0.0396	0.106	CbGbCtD
Dactinomycin—ABCC1—Epirubicin—testicular cancer	0.022	0.0589	CbGbCtD
Dactinomycin—ABCC1—Vinblastine—testicular cancer	0.019	0.051	CbGbCtD
Dactinomycin—ABCC1—Etoposide—testicular cancer	0.0171	0.0459	CbGbCtD
Dactinomycin—ABCG2—Carboplatin—testicular cancer	0.0137	0.0366	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—testicular cancer	0.0117	0.0313	CbGbCtD
Dactinomycin—ABCG2—Cisplatin—testicular cancer	0.0117	0.0313	CbGbCtD
Dactinomycin—ABCG2—Etoposide—testicular cancer	0.0115	0.0307	CbGbCtD
Dactinomycin—ABCC1—Methotrexate—testicular cancer	0.0113	0.0303	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—testicular cancer	0.00782	0.021	CbGbCtD
Dactinomycin—ABCG2—Methotrexate—testicular cancer	0.00758	0.0203	CbGbCtD
Dactinomycin—ABCB1—Vinblastine—testicular cancer	0.00459	0.0123	CbGbCtD
Dactinomycin—ABCB1—Cisplatin—testicular cancer	0.00421	0.0113	CbGbCtD
Dactinomycin—ABCB1—Etoposide—testicular cancer	0.00414	0.0111	CbGbCtD
Dactinomycin—ABCB1—Doxorubicin—testicular cancer	0.00282	0.00756	CbGbCtD
Dactinomycin—ABCB1—Methotrexate—testicular cancer	0.00273	0.00732	CbGbCtD
Dactinomycin—ABCC6—Podofilox—Etoposide—testicular cancer	0.00168	1	CbGdCrCtD
Dactinomycin—Alopecia—Ifosfamide—testicular cancer	0.000141	0.00179	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00014	0.00178	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.000139	0.00176	CcSEcCtD
Dactinomycin—Erythema—Ifosfamide—testicular cancer	0.000139	0.00176	CcSEcCtD
Dactinomycin—Myalgia—Bleomycin—testicular cancer	0.000138	0.00175	CcSEcCtD
Dactinomycin—Ulcer—Doxorubicin—testicular cancer	0.000137	0.00174	CcSEcCtD
Dactinomycin—Stomatitis—Etoposide—testicular cancer	0.000136	0.00173	CcSEcCtD
Dactinomycin—Discomfort—Bleomycin—testicular cancer	0.000136	0.00173	CcSEcCtD
Dactinomycin—Decreased appetite—Vinblastine—testicular cancer	0.000136	0.00173	CcSEcCtD
Dactinomycin—Mouth ulceration—Methotrexate—testicular cancer	0.000136	0.00172	CcSEcCtD
Dactinomycin—Body temperature increased—Chlorambucil—testicular cancer	0.000135	0.00172	CcSEcCtD
Dactinomycin—Abdominal pain—Chlorambucil—testicular cancer	0.000135	0.00172	CcSEcCtD
Dactinomycin—Pain—Vinblastine—testicular cancer	0.000134	0.0017	CcSEcCtD
Dactinomycin—Oedema—Bleomycin—testicular cancer	0.000132	0.00168	CcSEcCtD
Dactinomycin—Aplastic anaemia—Epirubicin—testicular cancer	0.000132	0.00167	CcSEcCtD
Dactinomycin—Infection—Bleomycin—testicular cancer	0.000131	0.00167	CcSEcCtD
Dactinomycin—Agranulocytosis—Etoposide—testicular cancer	0.000131	0.00166	CcSEcCtD
Dactinomycin—Sepsis—Methotrexate—testicular cancer	0.00013	0.00165	CcSEcCtD
Dactinomycin—Thrombocytopenia—Bleomycin—testicular cancer	0.00013	0.00164	CcSEcCtD
Dactinomycin—Feeling abnormal—Vinblastine—testicular cancer	0.000129	0.00164	CcSEcCtD
Dactinomycin—Ill-defined disorder—Ifosfamide—testicular cancer	0.000129	0.00163	CcSEcCtD
Dactinomycin—Oesophagitis—Epirubicin—testicular cancer	0.000128	0.00163	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Vinblastine—testicular cancer	0.000128	0.00163	CcSEcCtD
Dactinomycin—Anaemia—Ifosfamide—testicular cancer	0.000128	0.00163	CcSEcCtD
Dactinomycin—Flushing—Cisplatin—testicular cancer	0.000127	0.00162	CcSEcCtD
Dactinomycin—Mouth ulceration—Epirubicin—testicular cancer	0.000127	0.00161	CcSEcCtD
Dactinomycin—Anorexia—Bleomycin—testicular cancer	0.000126	0.0016	CcSEcCtD
Dactinomycin—Hypersensitivity—Chlorambucil—testicular cancer	0.000126	0.0016	CcSEcCtD
Dactinomycin—Malaise—Ifosfamide—testicular cancer	0.000125	0.00159	CcSEcCtD
Dactinomycin—Leukopenia—Ifosfamide—testicular cancer	0.000124	0.00157	CcSEcCtD
Dactinomycin—Abdominal pain—Vinblastine—testicular cancer	0.000124	0.00157	CcSEcCtD
Dactinomycin—Asthenia—Chlorambucil—testicular cancer	0.000123	0.00156	CcSEcCtD
Dactinomycin—Aplastic anaemia—Doxorubicin—testicular cancer	0.000122	0.00155	CcSEcCtD
Dactinomycin—Sepsis—Epirubicin—testicular cancer	0.000122	0.00155	CcSEcCtD
Dactinomycin—Alopecia—Cisplatin—testicular cancer	0.000121	0.00154	CcSEcCtD
Dactinomycin—Hepatic failure—Methotrexate—testicular cancer	0.000121	0.00154	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000121	0.00153	CcSEcCtD
Dactinomycin—Erythema—Cisplatin—testicular cancer	0.000119	0.00152	CcSEcCtD
Dactinomycin—Erythema multiforme—Etoposide—testicular cancer	0.000119	0.00151	CcSEcCtD
Dactinomycin—Oesophagitis—Doxorubicin—testicular cancer	0.000119	0.00151	CcSEcCtD
Dactinomycin—Phlebitis—Epirubicin—testicular cancer	0.000118	0.0015	CcSEcCtD
Dactinomycin—Myalgia—Ifosfamide—testicular cancer	0.000118	0.0015	CcSEcCtD
Dactinomycin—Mouth ulceration—Doxorubicin—testicular cancer	0.000117	0.00149	CcSEcCtD
Dactinomycin—Diarrhoea—Chlorambucil—testicular cancer	0.000117	0.00149	CcSEcCtD
Dactinomycin—Flushing—Etoposide—testicular cancer	0.000117	0.00148	CcSEcCtD
Dactinomycin—Discomfort—Ifosfamide—testicular cancer	0.000117	0.00148	CcSEcCtD
Dactinomycin—Hypersensitivity—Vinblastine—testicular cancer	0.000115	0.00147	CcSEcCtD
Dactinomycin—Decreased appetite—Bleomycin—testicular cancer	0.000115	0.00146	CcSEcCtD
Dactinomycin—Hepatic failure—Epirubicin—testicular cancer	0.000113	0.00144	CcSEcCtD
Dactinomycin—Pain—Bleomycin—testicular cancer	0.000113	0.00144	CcSEcCtD
Dactinomycin—Oedema—Ifosfamide—testicular cancer	0.000113	0.00144	CcSEcCtD
Dactinomycin—Chills—Etoposide—testicular cancer	0.000113	0.00143	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—testicular cancer	0.000113	0.00143	CcSEcCtD
Dactinomycin—Asthenia—Vinblastine—testicular cancer	0.000112	0.00143	CcSEcCtD
Dactinomycin—Infection—Ifosfamide—testicular cancer	0.000112	0.00143	CcSEcCtD
Dactinomycin—Alopecia—Etoposide—testicular cancer	0.000111	0.00141	CcSEcCtD
Dactinomycin—Lethargy—Methotrexate—testicular cancer	0.000111	0.00141	CcSEcCtD
Dactinomycin—Ill-defined disorder—Cisplatin—testicular cancer	0.000111	0.00141	CcSEcCtD
Dactinomycin—Thrombocytopenia—Ifosfamide—testicular cancer	0.000111	0.00141	CcSEcCtD
Dactinomycin—Anaemia—Cisplatin—testicular cancer	0.00011	0.0014	CcSEcCtD
Dactinomycin—Phlebitis—Doxorubicin—testicular cancer	0.000109	0.00139	CcSEcCtD
Dactinomycin—Feeling abnormal—Bleomycin—testicular cancer	0.000109	0.00138	CcSEcCtD
Dactinomycin—Vomiting—Chlorambucil—testicular cancer	0.000109	0.00138	CcSEcCtD
Dactinomycin—Anorexia—Ifosfamide—testicular cancer	0.000108	0.00137	CcSEcCtD
Dactinomycin—Malaise—Cisplatin—testicular cancer	0.000108	0.00137	CcSEcCtD
Dactinomycin—Diarrhoea—Vinblastine—testicular cancer	0.000107	0.00136	CcSEcCtD
Dactinomycin—Leukopenia—Cisplatin—testicular cancer	0.000107	0.00136	CcSEcCtD
Dactinomycin—Hepatic failure—Doxorubicin—testicular cancer	0.000105	0.00133	CcSEcCtD
Dactinomycin—Body temperature increased—Bleomycin—testicular cancer	0.000105	0.00133	CcSEcCtD
Dactinomycin—Lethargy—Epirubicin—testicular cancer	0.000104	0.00132	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000103	0.00131	CcSEcCtD
Dactinomycin—Myalgia—Cisplatin—testicular cancer	0.000102	0.00129	CcSEcCtD
Dactinomycin—Nausea—Chlorambucil—testicular cancer	0.000102	0.00129	CcSEcCtD
Dactinomycin—Ill-defined disorder—Etoposide—testicular cancer	0.000101	0.00129	CcSEcCtD
Dactinomycin—Anaemia—Etoposide—testicular cancer	0.000101	0.00128	CcSEcCtD
Dactinomycin—Liver function test abnormal—Methotrexate—testicular cancer	0.0001	0.00128	CcSEcCtD
Dactinomycin—Discomfort—Cisplatin—testicular cancer	0.0001	0.00128	CcSEcCtD
Dactinomycin—Vomiting—Vinblastine—testicular cancer	9.96e-05	0.00126	CcSEcCtD
Dactinomycin—Malaise—Etoposide—testicular cancer	9.87e-05	0.00125	CcSEcCtD
Dactinomycin—Decreased appetite—Ifosfamide—testicular cancer	9.83e-05	0.00125	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Methotrexate—testicular cancer	9.8e-05	0.00124	CcSEcCtD
Dactinomycin—Leukopenia—Etoposide—testicular cancer	9.79e-05	0.00124	CcSEcCtD
Dactinomycin—Fatigue—Ifosfamide—testicular cancer	9.75e-05	0.00124	CcSEcCtD
Dactinomycin—Oedema—Cisplatin—testicular cancer	9.75e-05	0.00124	CcSEcCtD
Dactinomycin—Hypersensitivity—Bleomycin—testicular cancer	9.74e-05	0.00124	CcSEcCtD
Dactinomycin—Infection—Cisplatin—testicular cancer	9.68e-05	0.00123	CcSEcCtD
Dactinomycin—Pain—Ifosfamide—testicular cancer	9.67e-05	0.00123	CcSEcCtD
Dactinomycin—Lethargy—Doxorubicin—testicular cancer	9.61e-05	0.00122	CcSEcCtD
Dactinomycin—Thrombocytopenia—Cisplatin—testicular cancer	9.54e-05	0.00121	CcSEcCtD
Dactinomycin—Asthenia—Bleomycin—testicular cancer	9.49e-05	0.00121	CcSEcCtD
Dactinomycin—Liver function test abnormal—Epirubicin—testicular cancer	9.4e-05	0.00119	CcSEcCtD
Dactinomycin—Feeling abnormal—Ifosfamide—testicular cancer	9.32e-05	0.00118	CcSEcCtD
Dactinomycin—Nausea—Vinblastine—testicular cancer	9.3e-05	0.00118	CcSEcCtD
Dactinomycin—Anorexia—Cisplatin—testicular cancer	9.29e-05	0.00118	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Ifosfamide—testicular cancer	9.24e-05	0.00117	CcSEcCtD
Dactinomycin—Discomfort—Etoposide—testicular cancer	9.2e-05	0.00117	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Epirubicin—testicular cancer	9.17e-05	0.00116	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Epirubicin—testicular cancer	9.17e-05	0.00116	CcSEcCtD
Dactinomycin—Body temperature increased—Ifosfamide—testicular cancer	8.94e-05	0.00114	CcSEcCtD
Dactinomycin—Abdominal pain—Ifosfamide—testicular cancer	8.94e-05	0.00114	CcSEcCtD
Dactinomycin—Pancytopenia—Methotrexate—testicular cancer	8.93e-05	0.00113	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Cisplatin—testicular cancer	8.88e-05	0.00113	CcSEcCtD
Dactinomycin—Infection—Etoposide—testicular cancer	8.87e-05	0.00113	CcSEcCtD
Dactinomycin—Dysphagia—Epirubicin—testicular cancer	8.8e-05	0.00112	CcSEcCtD
Dactinomycin—Neutropenia—Methotrexate—testicular cancer	8.79e-05	0.00112	CcSEcCtD
Dactinomycin—Thrombocytopenia—Etoposide—testicular cancer	8.74e-05	0.00111	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—testicular cancer	8.7e-05	0.0011	CcSEcCtD
Dactinomycin—Anorexia—Etoposide—testicular cancer	8.51e-05	0.00108	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	8.48e-05	0.00108	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	8.48e-05	0.00108	CcSEcCtD
Dactinomycin—Decreased appetite—Cisplatin—testicular cancer	8.47e-05	0.00108	CcSEcCtD
Dactinomycin—Pneumonia—Methotrexate—testicular cancer	8.43e-05	0.00107	CcSEcCtD
Dactinomycin—Vomiting—Bleomycin—testicular cancer	8.41e-05	0.00107	CcSEcCtD
Dactinomycin—Pancytopenia—Epirubicin—testicular cancer	8.36e-05	0.00106	CcSEcCtD
Dactinomycin—Rash—Bleomycin—testicular cancer	8.34e-05	0.00106	CcSEcCtD
Dactinomycin—Pain—Cisplatin—testicular cancer	8.33e-05	0.00106	CcSEcCtD
Dactinomycin—Hypersensitivity—Ifosfamide—testicular cancer	8.33e-05	0.00106	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	8.31e-05	0.00106	CcSEcCtD
Dactinomycin—Neutropenia—Epirubicin—testicular cancer	8.23e-05	0.00105	CcSEcCtD
Dactinomycin—Stomatitis—Methotrexate—testicular cancer	8.17e-05	0.00104	CcSEcCtD
Dactinomycin—Dysphagia—Doxorubicin—testicular cancer	8.14e-05	0.00103	CcSEcCtD
Dactinomycin—Asthenia—Ifosfamide—testicular cancer	8.11e-05	0.00103	CcSEcCtD
Dactinomycin—Feeling abnormal—Cisplatin—testicular cancer	8.03e-05	0.00102	CcSEcCtD
Dactinomycin—Pneumonia—Epirubicin—testicular cancer	7.89e-05	0.001	CcSEcCtD
Dactinomycin—Nausea—Bleomycin—testicular cancer	7.86e-05	0.000998	CcSEcCtD
Dactinomycin—Agranulocytosis—Methotrexate—testicular cancer	7.82e-05	0.000994	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	7.78e-05	0.000988	CcSEcCtD
Dactinomycin—Decreased appetite—Etoposide—testicular cancer	7.76e-05	0.000986	CcSEcCtD
Dactinomycin—Diarrhoea—Ifosfamide—testicular cancer	7.73e-05	0.000982	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—testicular cancer	7.73e-05	0.000982	CcSEcCtD
Dactinomycin—Body temperature increased—Cisplatin—testicular cancer	7.7e-05	0.000979	CcSEcCtD
Dactinomycin—Fatigue—Etoposide—testicular cancer	7.7e-05	0.000978	CcSEcCtD
Dactinomycin—Stomatitis—Epirubicin—testicular cancer	7.65e-05	0.000972	CcSEcCtD
Dactinomycin—Pain—Etoposide—testicular cancer	7.63e-05	0.00097	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—testicular cancer	7.61e-05	0.000967	CcSEcCtD
Dactinomycin—Hepatitis—Methotrexate—testicular cancer	7.53e-05	0.000956	CcSEcCtD
Dactinomycin—Pharyngitis—Methotrexate—testicular cancer	7.47e-05	0.000949	CcSEcCtD
Dactinomycin—Feeling abnormal—Etoposide—testicular cancer	7.36e-05	0.000934	CcSEcCtD
Dactinomycin—Agranulocytosis—Epirubicin—testicular cancer	7.32e-05	0.00093	CcSEcCtD
Dactinomycin—Pneumonia—Doxorubicin—testicular cancer	7.3e-05	0.000928	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Etoposide—testicular cancer	7.3e-05	0.000927	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	7.2e-05	0.000914	CcSEcCtD
Dactinomycin—Vomiting—Ifosfamide—testicular cancer	7.19e-05	0.000913	CcSEcCtD
Dactinomycin—Hypersensitivity—Cisplatin—testicular cancer	7.18e-05	0.000912	CcSEcCtD
Dactinomycin—Rash—Ifosfamide—testicular cancer	7.13e-05	0.000905	CcSEcCtD
Dactinomycin—Erythema multiforme—Methotrexate—testicular cancer	7.12e-05	0.000904	CcSEcCtD
Dactinomycin—Stomatitis—Doxorubicin—testicular cancer	7.08e-05	0.000899	CcSEcCtD
Dactinomycin—Abdominal pain—Etoposide—testicular cancer	7.06e-05	0.000896	CcSEcCtD
Dactinomycin—Body temperature increased—Etoposide—testicular cancer	7.06e-05	0.000896	CcSEcCtD
Dactinomycin—Hepatitis—Epirubicin—testicular cancer	7.04e-05	0.000895	CcSEcCtD
Dactinomycin—Asthenia—Cisplatin—testicular cancer	6.99e-05	0.000888	CcSEcCtD
Dactinomycin—Pharyngitis—Epirubicin—testicular cancer	6.99e-05	0.000888	CcSEcCtD
Dactinomycin—Agranulocytosis—Doxorubicin—testicular cancer	6.78e-05	0.000861	CcSEcCtD
Dactinomycin—Chills—Methotrexate—testicular cancer	6.75e-05	0.000858	CcSEcCtD
Dactinomycin—Nausea—Ifosfamide—testicular cancer	6.71e-05	0.000853	CcSEcCtD
Dactinomycin—Diarrhoea—Cisplatin—testicular cancer	6.67e-05	0.000847	CcSEcCtD
Dactinomycin—Erythema multiforme—Epirubicin—testicular cancer	6.66e-05	0.000846	CcSEcCtD
Dactinomycin—Alopecia—Methotrexate—testicular cancer	6.65e-05	0.000845	CcSEcCtD
Dactinomycin—Hypersensitivity—Etoposide—testicular cancer	6.58e-05	0.000836	CcSEcCtD
Dactinomycin—Erythema—Methotrexate—testicular cancer	6.55e-05	0.000832	CcSEcCtD
Dactinomycin—Flushing—Epirubicin—testicular cancer	6.54e-05	0.00083	CcSEcCtD
Dactinomycin—Hepatitis—Doxorubicin—testicular cancer	6.52e-05	0.000828	CcSEcCtD
Dactinomycin—Pharyngitis—Doxorubicin—testicular cancer	6.47e-05	0.000822	CcSEcCtD
Dactinomycin—Asthenia—Etoposide—testicular cancer	6.41e-05	0.000814	CcSEcCtD
Dactinomycin—Chills—Epirubicin—testicular cancer	6.32e-05	0.000803	CcSEcCtD
Dactinomycin—Alopecia—Epirubicin—testicular cancer	6.22e-05	0.000791	CcSEcCtD
Dactinomycin—Vomiting—Cisplatin—testicular cancer	6.2e-05	0.000787	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—testicular cancer	6.16e-05	0.000783	CcSEcCtD
Dactinomycin—Rash—Cisplatin—testicular cancer	6.14e-05	0.00078	CcSEcCtD
Dactinomycin—Erythema—Epirubicin—testicular cancer	6.13e-05	0.000779	CcSEcCtD
Dactinomycin—Diarrhoea—Etoposide—testicular cancer	6.11e-05	0.000776	CcSEcCtD
Dactinomycin—Ill-defined disorder—Methotrexate—testicular cancer	6.08e-05	0.000772	CcSEcCtD
Dactinomycin—Anaemia—Methotrexate—testicular cancer	6.06e-05	0.000769	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—testicular cancer	6.05e-05	0.000768	CcSEcCtD
Dactinomycin—Malaise—Methotrexate—testicular cancer	5.91e-05	0.000751	CcSEcCtD
Dactinomycin—Leukopenia—Methotrexate—testicular cancer	5.87e-05	0.000745	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—testicular cancer	5.85e-05	0.000743	CcSEcCtD
Dactinomycin—Nausea—Cisplatin—testicular cancer	5.79e-05	0.000735	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—testicular cancer	5.76e-05	0.000732	CcSEcCtD
Dactinomycin—Ill-defined disorder—Epirubicin—testicular cancer	5.69e-05	0.000723	CcSEcCtD
Dactinomycin—Vomiting—Etoposide—testicular cancer	5.68e-05	0.000721	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—testicular cancer	5.67e-05	0.000721	CcSEcCtD
Dactinomycin—Anaemia—Epirubicin—testicular cancer	5.67e-05	0.00072	CcSEcCtD
Dactinomycin—Rash—Etoposide—testicular cancer	5.63e-05	0.000715	CcSEcCtD
Dactinomycin—Myalgia—Methotrexate—testicular cancer	5.58e-05	0.000709	CcSEcCtD
Dactinomycin—Malaise—Epirubicin—testicular cancer	5.53e-05	0.000702	CcSEcCtD
Dactinomycin—Discomfort—Methotrexate—testicular cancer	5.51e-05	0.0007	CcSEcCtD
Dactinomycin—Leukopenia—Epirubicin—testicular cancer	5.49e-05	0.000697	CcSEcCtD
Dactinomycin—Infection—Methotrexate—testicular cancer	5.31e-05	0.000675	CcSEcCtD
Dactinomycin—Nausea—Etoposide—testicular cancer	5.3e-05	0.000674	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—testicular cancer	5.26e-05	0.000669	CcSEcCtD
Dactinomycin—Anaemia—Doxorubicin—testicular cancer	5.24e-05	0.000666	CcSEcCtD
Dactinomycin—Thrombocytopenia—Methotrexate—testicular cancer	5.24e-05	0.000665	CcSEcCtD
Dactinomycin—Myalgia—Epirubicin—testicular cancer	5.22e-05	0.000663	CcSEcCtD
Dactinomycin—Discomfort—Epirubicin—testicular cancer	5.16e-05	0.000655	CcSEcCtD
Dactinomycin—Malaise—Doxorubicin—testicular cancer	5.12e-05	0.00065	CcSEcCtD
Dactinomycin—Anorexia—Methotrexate—testicular cancer	5.1e-05	0.000647	CcSEcCtD
Dactinomycin—Leukopenia—Doxorubicin—testicular cancer	5.08e-05	0.000645	CcSEcCtD
Dactinomycin—Oedema—Epirubicin—testicular cancer	5e-05	0.000636	CcSEcCtD
Dactinomycin—Infection—Epirubicin—testicular cancer	4.97e-05	0.000632	CcSEcCtD
Dactinomycin—Thrombocytopenia—Epirubicin—testicular cancer	4.9e-05	0.000622	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Methotrexate—testicular cancer	4.87e-05	0.000619	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—testicular cancer	4.83e-05	0.000614	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—testicular cancer	4.77e-05	0.000606	CcSEcCtD
Dactinomycin—Anorexia—Epirubicin—testicular cancer	4.77e-05	0.000606	CcSEcCtD
Dactinomycin—Decreased appetite—Methotrexate—testicular cancer	4.65e-05	0.00059	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—testicular cancer	4.63e-05	0.000588	CcSEcCtD
Dactinomycin—Fatigue—Methotrexate—testicular cancer	4.61e-05	0.000586	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—testicular cancer	4.6e-05	0.000584	CcSEcCtD
Dactinomycin—Pain—Methotrexate—testicular cancer	4.57e-05	0.000581	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Epirubicin—testicular cancer	4.56e-05	0.000579	CcSEcCtD
Dactinomycin—Thrombocytopenia—Doxorubicin—testicular cancer	4.53e-05	0.000576	CcSEcCtD
Dactinomycin—Anorexia—Doxorubicin—testicular cancer	4.41e-05	0.000561	CcSEcCtD
Dactinomycin—Feeling abnormal—Methotrexate—testicular cancer	4.41e-05	0.00056	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Methotrexate—testicular cancer	4.37e-05	0.000555	CcSEcCtD
Dactinomycin—Decreased appetite—Epirubicin—testicular cancer	4.35e-05	0.000553	CcSEcCtD
Dactinomycin—Fatigue—Epirubicin—testicular cancer	4.31e-05	0.000548	CcSEcCtD
Dactinomycin—Pain—Epirubicin—testicular cancer	4.28e-05	0.000544	CcSEcCtD
Dactinomycin—Body temperature increased—Methotrexate—testicular cancer	4.23e-05	0.000537	CcSEcCtD
Dactinomycin—Abdominal pain—Methotrexate—testicular cancer	4.23e-05	0.000537	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	4.22e-05	0.000536	CcSEcCtD
Dactinomycin—Feeling abnormal—Epirubicin—testicular cancer	4.12e-05	0.000524	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Epirubicin—testicular cancer	4.09e-05	0.00052	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—testicular cancer	4.03e-05	0.000511	CcSEcCtD
Dactinomycin—Fatigue—Doxorubicin—testicular cancer	3.99e-05	0.000507	CcSEcCtD
Dactinomycin—Pain—Doxorubicin—testicular cancer	3.96e-05	0.000503	CcSEcCtD
Dactinomycin—Body temperature increased—Epirubicin—testicular cancer	3.96e-05	0.000503	CcSEcCtD
Dactinomycin—Abdominal pain—Epirubicin—testicular cancer	3.96e-05	0.000503	CcSEcCtD
Dactinomycin—Hypersensitivity—Methotrexate—testicular cancer	3.94e-05	0.0005	CcSEcCtD
Dactinomycin—Asthenia—Methotrexate—testicular cancer	3.84e-05	0.000487	CcSEcCtD
Dactinomycin—Feeling abnormal—Doxorubicin—testicular cancer	3.82e-05	0.000485	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—testicular cancer	3.79e-05	0.000481	CcSEcCtD
Dactinomycin—Hypersensitivity—Epirubicin—testicular cancer	3.69e-05	0.000468	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—testicular cancer	3.66e-05	0.000465	CcSEcCtD
Dactinomycin—Body temperature increased—Doxorubicin—testicular cancer	3.66e-05	0.000465	CcSEcCtD
Dactinomycin—Diarrhoea—Methotrexate—testicular cancer	3.66e-05	0.000465	CcSEcCtD
Dactinomycin—Asthenia—Epirubicin—testicular cancer	3.59e-05	0.000456	CcSEcCtD
Dactinomycin—Diarrhoea—Epirubicin—testicular cancer	3.42e-05	0.000435	CcSEcCtD
Dactinomycin—Hypersensitivity—Doxorubicin—testicular cancer	3.41e-05	0.000433	CcSEcCtD
Dactinomycin—Vomiting—Methotrexate—testicular cancer	3.4e-05	0.000432	CcSEcCtD
Dactinomycin—Rash—Methotrexate—testicular cancer	3.37e-05	0.000428	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—testicular cancer	3.32e-05	0.000422	CcSEcCtD
Dactinomycin—Vomiting—Epirubicin—testicular cancer	3.18e-05	0.000404	CcSEcCtD
Dactinomycin—Nausea—Methotrexate—testicular cancer	3.18e-05	0.000403	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—testicular cancer	3.17e-05	0.000402	CcSEcCtD
Dactinomycin—Rash—Epirubicin—testicular cancer	3.16e-05	0.000401	CcSEcCtD
Dactinomycin—Nausea—Epirubicin—testicular cancer	2.97e-05	0.000378	CcSEcCtD
Dactinomycin—Vomiting—Doxorubicin—testicular cancer	2.94e-05	0.000374	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—testicular cancer	2.92e-05	0.000371	CcSEcCtD
Dactinomycin—Nausea—Doxorubicin—testicular cancer	2.75e-05	0.000349	CcSEcCtD
